| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 4,150 | 0 | 0 | 4,150 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| MORGAN STANLEY MED TERM NOTE | 75,000 | 74,813 |
| SERENE LLC | 200,000 | 200,000 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| I SHARES MSCI EMERGING MKT | 35,201 | 54,684 |
| I SHARES S&P BARRA GROWTH | 52,830 | 135,603 |
| I SHARES S&P 500 VALUE | 44,884 | 70,798 |
| I SHARES RUSSELL 2000 | 17,898 | 33,475 |
| BIOMARIN PHARMACEUTICAL | 60,300 | 85,150 |
| GUARDIAN 8 HOLDINGS | 50,000 | 313 |
| SUPERNUS PHARMACEUTICALS | 22,158 | 66,440 |
| MESOBLAST LTD SPON ADR | 78,690 | 51,500 |
| ENZYMOTEC LTD |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| QCA FIRST FUND IV, LLC | FMV | 14,668 | 52,062 |
| HEALTHCARE ASSET NETWORK, INC. | FMV | 101,180 | 101,180 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ANNUAL REPORT FILING | 15 | 15 | ||
| NON DEDUCTIBLE | 58 | |||
| QCA | 9,498 | 9,498 | ||
| TRUST FEES | 87 | 87 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| AGENCY & INVESTMENT FEES | 7,016 | 7,016 | 0 | 0 |
| BANK FEES | 193 | 193 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 177 | 177 |